Reprise Biomedical Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$14.2M
- Investors
-
2
Reprise Biomedical General Information
Description
Operator of a biological medical device company intended to develop and commercialize biologic medical devices. The company offers biologic wound matrices and soft tissue reinforcement products manufactured using proprietary perfusion decellularization technology, enabling healthcare providers to manage wounds and reinforce soft tissue.
Contact Information
Website
www.reprisebio.comCorporate Office
- 17400 Medina Road
- Suite 100
- Plymouth, MN 55447
- United States
Corporate Office
- 17400 Medina Road
- Suite 100
- Plymouth, MN 55447
- United States
Reprise Biomedical Timeline
Reprise Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Jul-2026 | $14.2M | Completed | Generating Revenue | ||
| 6. Early Stage VC | 13-Dec-2023 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 25-Jan-2023 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 30-Mar-2021 | Completed | Generating Revenue | |||
| 3. Debt - PPP | 06-Apr-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 12-Jul-2019 | $12.5M | $12.5M | Completed | Startup | |
| 1. Spin-Off | 01-Jan-2019 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Reprise Biomedical Patents
Reprise Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240424276-A1 | Wound management assemblies, kits, and methods | Pending | 21-Jun-2023 | ||
| US-20250049989-A1 | Tunnel filler device and methods of use | Pending | 31-May-2022 | ||
| WO-2023235737-A1 | Tunnel filler device and methods of use | Inactive | 31-May-2022 | ||
| US-11998662-B1 | Biologic matrix for a wound site and related methods | Active | 09-Jun-2021 | ||
| US-12115284-B1 | Biologic matrix for a wound site and related methods | Active | 09-Jun-2021 | A61L27/56 |
Reprise Biomedical Signals
Reprise Biomedical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| John Lilly Strategic Insights | Corporation | Minority | ||
| Lateral Capital Management | Venture Capital | Minority |
Reprise Biomedical FAQs
-
When was Reprise Biomedical founded?
Reprise Biomedical was founded in 2019.
-
Where is Reprise Biomedical headquartered?
Reprise Biomedical is headquartered in Plymouth, MN.
-
What is the size of Reprise Biomedical?
Reprise Biomedical has 50 total employees.
-
What industry is Reprise Biomedical in?
Reprise Biomedical’s primary industry is Medical Supplies.
-
Is Reprise Biomedical a private or public company?
Reprise Biomedical is a Private company.
-
What is Reprise Biomedical’s current revenue?
The current revenue for Reprise Biomedical is .
-
How much funding has Reprise Biomedical raised over time?
Reprise Biomedical has raised $54.9M.
-
Who are Reprise Biomedical’s investors?
John Lilly Strategic Insights and Lateral Capital Management have invested in Reprise Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process